Desflurane as a marker of limb-to-systemic leak during hyperthermic isolated limb perfusion

Anesthesiology

Volumn 93, Issue 2, 2000, Pages 574-576

  Stanley, Glynne ^a,d   Sundarakumaran, Rengasamy ^a   Crowley, Richard ^b   Kavanah, Maureen ^c  

^a Division of Anesthesiology   (United States)

^b Division of Cardiothoracic Surgery

^c Section of Surgical Oncology

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Melanoma; Monitoring; Systemic leakage

Indexed keywords

ANTINEOPLASTIC AGENT; DESFLURANE; FENTANYL; PROPOFOL; ROCURONIUM;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CANCER CHEMOTHERAPY; CASE REPORT; HUMAN; LIMB PERFUSION; MALE; MELANOMA; PRIORITY JOURNAL;

EID: 0033859033     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200008000-00042     Document Type: Article

References (10)

1. Chemotherapy of cancer: Regional perfusion utilizing an extracorporeal circuit
2. Hyperthermic perfusion with chemotherapy for melanoma of the extremities
3. Hyperthermic antiblastic perfusion in extracorporeal circulation: Surgical technique and results in the treatment of extremities' tumor
4. The treatment of stage I melanoma of the extermities with regional hyperthermic isolation perfusion
5. Tourniquet infusion versus hyperthermic perfusion
6. Systemic leakage during isolated limb perfusion for melanoma
7. Desflurane clinical pharmacokinetics and pharmaco-dynamics
8. Kinetics of desflurane, isoflurane and halothane in humans